Treatment options are limited for the 3-5% of patients who have cancers of unknown primary. So, we are excited to present 💥GDD-ENS💥: a highly accurate, comprehensive tumor type classifier based on data from a routinely applied FDA-authorized test 🧵 medrxiv.org/content/10.110…

So excited to announce that my most recent work has been published. If you’re interested in genetically encoding circular mRNA, or packaging circular mRNA into virus-like particles for cell-type specific delivery, this paper is for you!

This is one of the better reviews I've read. We have to think about both formation rates and fitness impacts to understand how complex events contribute to tumorigenesis, mets, drug resistance, etc. Worth the read even if you've been thinking about these problems for a while

Thrilled to announce that my PhD thesis work has been published in Nature Genetics! 🎉 Huge thanks to my advisors, Sohrab Shah and Ed Reznik, for their guidance and support throughout the years!

I’m happy to announce that I will be defending my PhD thesis two weeks from now! My defense will be a tour of all my favorite bits of research over the past 4.5 years, spanning both ML algorithm development and single-cell analysis. Register below: weillcornell.zoom.us/meeting/regist…

Come for the linear time OT, stay for the interpolation bw lamp & toilet. Great work Doron!

Very excited to share our article detailing spatial features of Epstein-Barr virus positive and negative classic Hodgkin lymphoma featured on the Cover of Clinical Cancer Research! aacrjournals.org/clincancerres/…

We posted a couple of preprints recently, quick summary below 👇

I officially started my postdoc in Barbara Engelhardt 's lab at Gladstone Institutes last month!! I’m working with some phenomenal collaborators to improve cancer immunotherapy using genomic and spatiotemporal data. Excited to meet those at the UC San Francisco Mission Bay and Stanford University campuses!